Syndax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.
CEOMichael A. Metzger
CEOMichael A. Metzger
Employees270
Employees270
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2005
Founded2005
Employees270
Employees270
SNDX Key Statistics
Market cap855.31M
Market cap855.31M
Price-Earnings ratio-2.57
Price-Earnings ratio-2.57
Dividend yield—
Dividend yield—
Average volume3.16M
Average volume3.16M
High today$10.15
High today$10.15
Low today$9.84
Low today$9.84
Open price$9.95
Open price$9.95
Volume2.49M
Volume2.49M
52 Week high$25.07
52 Week high$25.07
52 Week low$8.58
52 Week low$8.58
SNDX News
Simply Wall St 7d
Nicholas Botwood Bought 50% More Shares In Syndax PharmaceuticalsInvestors who take an interest in Syndax Pharmaceuticals, Inc. ( ) should definitely note that insider Nicholas Botwood recently paid US$9.00 per share to buy U...
Analyst ratings
92%
of 13 ratingsBuy
92.3%
Hold
7.7%
Sell
0%
People also own
Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.